Even more promising for weight loss, a 40-week study of 475 participants with diabetes published in 2022 in the Journal of the American Medical Association ( JAMA ) found that those on a 15 mg dose of tirzepatide lost an average of 19 pounds as compared to the placebo group who actually gained almost four pounds during the trial
Complementary Ingredients It works beneficially when combined with other skin-supporting ingredients
GLP-1 receptor agonists also reduce the three components of MACE, including CV mortality (reduced by 13%), nonfatal stroke (reduced by 16%) and nonfatal myocardial infarction (reduced by 9%, although the level of significance was not reached)
It is also thought to increase fatty acid mobilization
Pramanik, J., Kumar, A., Panchal, L
Oral Surg Oral Med Oral Pathol 1993;76:5961